ストックスクリーナーアプリを入手
10.57
1.10%
0.12
前日終値:
$10.45
開ける：
$10.45
24時間の取引高:
61,679
Relative Volume:
0.08
時価総額：
$373.62M
収益：
$2.07M
当期純損益:
$-47.68M
株価収益率:
-3.7482
EPS:
-2.82
ネットキャッシュフロー:
$-31.31M
1週間 パフォーマンス:
+4.60%
1か月 パフォーマンス:
+8.03%
6か月 パフォーマンス:
-13.68%
1年 パフォーマンス:
-14.11%
1日の値動き範囲:
$10.42
$10.64
1週間の範囲:
$9.69
$10.64
52週間の値動き範囲:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
名前
Delcath Systems Inc
セクター
電話
(518) 743-8892
住所
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.58 | 369.03M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
126.91 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.45 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.76 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.58 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Craig Hallum | Buy |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2022-07-26 | 再開されました | Canaccord Genuity | Buy |
| 2021-12-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Canaccord Genuity | Buy |
| 2021-01-05 | 開始されました | BTIG Research | Buy |
| 2020-06-01 | 開始されました | Laidlaw | Buy |
すべてを表示
Delcath Systems Inc (DCTH) 最新ニュース
Under the Radar: 3 Microcap Growers Passing a Tough Test - Benzinga
(DCTH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Yahoo Finance
Are options traders betting on a big move in Delcath Systems stock? - MSN
Delcath Systems Inc Stock Analysis and ForecastLong-Term Growth Stocks & Fast Growing Investment Plans - earlytimes.in
Hepzato Kit Safe, Effective in Metastatic, Unresectable Uveal Melanoma - Cure Today
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Yahoo Finance
Delcath Systems publishes results from subgroup analyses of FOCUS study - Yahoo Finance
Delcath’s HEPZATO shows consistent efficacy across patient subgroups By Investing.com - Investing.com Nigeria
Delcath’s HEPZATO shows consistent efficacy across patient subgroups - Investing.com India
Delcath Systems (DCTH) Reveals Key Findings from FOCUS Study Sub - GuruFocus
Which metastatic uveal melanoma patients gain most from a liver-directed drug? - Stock Titan
Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH - MarketBeat
Glenmark Pharmaceuticals Limited (532296) Gets Regulatory ApprovalFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Book value per share of Delcath Systems, Inc. – MUN:DV3R - TradingView — Track All Markets
Bearish Setup: Is Delcath Systems Inc stock a smart buy before Fed meetingTrade Entry Summary & Advanced Technical Signal Analysis - moha.gov.vn
Precision Trading with Delcath Systems Inc. (DCTH) Risk Zones - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Delcath Systems (STU:DV3R) EV-to-OCF : 19.88 (As of Dec. 21, 2025) - GuruFocus
Why Delcath Systems Inc. (DV3R) stock stays on buy lists2025 Biggest Moves & Entry Point Strategy Guides - bolumsonucanavari.com
Delcath Systems Earnings Notes - Trefis
Delcath Systems authorizes $25 million share repurchase program - MSN
Can Delcath Systems Inc. (DV3R) stock hold up in economic slowdownCEO Change & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
Will Delcath Systems Inc. (DV3R) stock sustain bullish trend into 2025Inflation Watch & Long-Term Safe Return Strategies - DonanımHaber
Is Delcath Systems Inc. stock a safe haven assetPortfolio Return Report & Reliable Intraday Trade Plans - Улправда
Will Delcath Systems Inc. stock sustain high P E ratiosPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Here’s What Hit Delcath Systems (DCTH) in Q3 - Insider Monkey
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates - sharewise.com
How higher bond yields impact Delcath Systems Inc. (DV3R) stock2025 Key Highlights & High Conviction Investment Ideas - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Why Delcath Systems Inc. (DV3R) stock trades below fair valueQuarterly Trade Report & Daily Stock Trend Reports - Newser
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - BioSpace
Delcath reports 29-month survival in liver cancer treatment study - Investing.com India
Delcath reports 29-month survival in liver cancer treatment study By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Showcases Promising Study Results for Liv - GuruFocus
Is Delcath Systems Inc. stock a top pick in earnings seasonJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years - Yahoo Finance
(DCTH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Delcath Systems (DCTH) Competitors and Alternatives 2025 - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Dir Sylvester Buys 4,386 ($39K) Of Delcath Sys Inc [DCTH] - TradingView
Delcath Systems Inc (DCTH) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
0.98%
大文字化:
|
ボリューム (24 時間):